Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 3;8:805812. doi: 10.3389/fcvm.2021.805812

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Hu, Zhou, Li, Zhao, Sun, Fan and Zhang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Distinct gut microbiome in different groups. (A,B) Phylum-level and genus-level composition of gut microbiome in patients with CHD-NAFLD, patients with CHD, and healthy controls (HC). (C) Differential bacteria at class-level between CHD-NAFLD group and CHD group. (D) Species-level alterations in gut microbiome in CHD-NAFLD, CHD, HC groups. Stars are marked for significant enrichment or depletion either in the CHD-NAFLD group, CHD group, or in the HC group. (E) The summed relative abundances of gut microbes were compared between the CHD-NAFLD and CHD groups based on species-level. (F) Spearman correlation between key gut microbiomes and altered serum metabolites. Red font: gut microbiomes enriched in CHD-NAFLD. Black font: gut microbiomes depleted in CHD-NAFLD. Pink font: serum metabolites enriched in CHD-NAFLD. Green font: serum metabolites depleted in CHD-NAFLD. *P < 0.05, **P < 0.01.